TY  - JOUR
TI  - Synthesis and potential antitumor activities of mandelic
acid linked 2-aryl-1,3-thiazolidin-4-ones
AB  - In our pursuit to discover new anticancer agents, we have synthesized a new series of 2-aryl-1,3-
thiazolidin-4-one derivatives carrying a mandelic acid part. Compounds 3a-h and 4a-j have been synthesized with the
cyclization of mandelic acid-derived Schiff bases, their structures have been elucidated with spectral methods (1H-NMR,
13C-NMR, and LC/MS-APCI) and elemental analyzes (C, H, N). Five compounds 3d, 3e, 4e, 4f, and 4g chosen as
prototypes were evaluated against the full panel of 58 human tumor cell lines in the National Cancer Institute’s in vitro
primary cytotoxicity assay (Bethesda, Maryland). Among the tested compound, 3e showed good cytotoxic effects
against melanoma cell line UACC-62. Compounds 3d, 4e, 4f, and 4g showed moderate cytotoxic effects, especially
against leukemia cell line, RPMI-8226, non-small cell lung cancer cell lines NCI-H23 and HOP-92, central nervous
system (CNS) cancer cell lines SF-295 and SNB-75, melanoma cell line UACC-62, and ovarian cancer cell line IGROV1.
It is considered that the in vitro test results of selected compounds are promising and an additional mandelic acid moiety
to core structure 2-aryl-1,3-thiazolidin-4-one and different modifications may result in effective agents in anticancer
treatment.
AU  - YAZICI, Kübra DEMİR
AU  - AKDEMİR, Özlen GÜZEL
DO  - 10.29228/jrp.191
PY  - 2022
JO  - Journal of research in pharmacy (online)
VL  - 26
IS  - 4
SN  - 2630-6344
SP  - 931
EP  - 940
DB  - TRDizin
UR  - http://search/yayin/detay/535932
ER  -